NCT07169331 2025-12-19A Study to Evaluate the Efficacy and Safety of Zanubrutinib in Chinese Adults With Treatment-Naive Waldenström MacroglobulinemiaBeOne MedicinesPhase 4 Recruiting18 enrolled